ELI LILLY & Co — Director's Dealing 2016

Dec 19, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LILLY ELI & CO (LLY)
CIK: 0000059478
Period of Report: 2016-12-16

Reporting Person: Mahony Susan (SVP & Pres., Lilly Oncology)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-12-16	Common Stock	S	19093	$72.65	Disposed	67802	Direct
2016-12-16	Common Stock	G	737	—	Disposed	67065	Direct
2016-12-16	Common Stock	S	1149	$72.68	Disposed	11479	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	1685	Indirect
Common Stock	1674	Indirect

Footnotes

F1: Reporting person disclaims beneficial ownership of these shares.